ABRILADA
Live / Registered — Registered (as of 16 Jan 2024)
What this means for you
Registered since 16 Jan 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90229278
- Registration number
- 7279703
- Mark type
- Stylized text
- Filed
- 01 Oct 2020
- Published for opposition
- 06 Apr 2021
- Registered
- 16 Jan 2024
- Attorney of record
- Andrea Christensen
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of autoimmune, inflammatory diseases and disorders; pharmaceutical preparations for the treatment of skin disorders, arthritis
Owner
- Pfizer Inc., New York, NY, US
- Pfizer Inc., New York, NY, US
- Pfizer Inc., New York, NY, US
Prosecution history
- 29 Jan 2026 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 29 Jan 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 29 Jan 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 29 Jan 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 22 Jan 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 17 Jan 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 16 Jan 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 16 Jan 2024 — REGISTERED-PRINCIPAL REGISTER
- 12 Dec 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 11 Dec 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 09 Dec 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 21 Nov 2023 — USE AMENDMENT FILED
- 05 Dec 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 30 Nov 2023 — ASSIGNED TO EXAMINER
- 21 Nov 2023 — TEAS STATEMENT OF USE RECEIVED